Zobrazeno 1 - 10
of 362
pro vyhledávání: '"VOSKARIDOU E."'
Publikováno v:
HemaSphere, Vol 6, Pp 58-58 (2022)
Externí odkaz:
https://doaj.org/article/1aaf4d4318ed43fb8d006abed20f1b9e
Autor:
Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::06e1978e886b8743858502883552c10d
http://hdl.handle.net/11591/404561
http://hdl.handle.net/11591/404561
BACKGROUND Patients with transfusion-dependent β-thalassemia need regular red-cell transfusions. Luspatercept, a recombinant fusion protein that binds to select transforming growth factor β superfamily ligands, may enhance erythroid maturation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d65fb3b1b840e3960ecd85e22afd780e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104621
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104621
Background: Regular transfusions are the gold standard therapy for β-thalassemia and are often complicated by secondary-iron overload and alloimmunization. We assessed the frequency of regulatory T cells (Tregs) and the levels of cytokines implicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::dd76011410c7a89d071f00f01e99d960
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078803
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078803
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Aims: To investigate the effect of heterozygous β-thalassemia on HbA1c levels in a population without diabetes mellitus (DM). Methods: Using a cross-sectional design, HbA1c levels were compared between two groups of 100 consecutive carriers of β-th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::214ab680e45863a58bee9a8673cc8ad2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078423
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078423
Introduction: Noggin is an antagonist of bone morphogenetic proteins (BMPs) and has a strong effect on osteogenesis. Osteoporosis is a common complication of transfusion dependent beta-thalassemia (TDT) and denosumab has been recently emerged as a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::239b7c0e00227eeb8e36f19dfe873e22
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106642
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106642
Despite the advances in the management of hemoglobinopathies, further insight into disease pathophysiology is necessary to improve our therapeutic approach. Activin-A has emerged as a regulator of erythropoiesis and bone turnover in malignant disorde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::efea3f478c6c08a947ccd211cc0ec512
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122192
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122192
The clinical manifestations of Sickle Cell Disease (SCD) include episodes of vascular occlusion, chronic hemolytic anemia and frequent infections. GDF-15, a multifactorial cytokine, is a member of the transforming growth factor- superfamily. Expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::237684db0d03c1d9f0535b3fd8e42a14
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078095
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078095